Simtra BioPharma Solutions has purchased a 65-acre property with more than 300,000 square feet of available space for ...

Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.

The European Commission has approved Sanofi’s Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) ...

Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialize oral covalent inhibitors.

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Verastem Oncology’s VS-7375.

Stevanato Group has secured €200 million in financing intended to support its ongoing capital expenditure projects in ...

Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure.

Crown Bioscience’s San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification.

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) ...

BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

Ipsen, a global specialty care biopharmaceutical company, has made the following changes to its Executive Committee: ...

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...